Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Herein, we review the epitope approach to vaccine development, and discuss how knowledge of HLA supertypes might be used as a tool in the development of such vaccines. After reviewing the main structural features of the A2-, A3-, B7-, and B44- supertype alleles, and biological data demonstrating their immunological relevance, we analyze the frequency at which these supertype alleles are expressed in various ethnicities and discuss the relevance of those observations to vaccine development. Next, the existence of five new supertypes (A1, A24, B27, B58, and B62) is reported. As a result, it is possible to account for the predominance of all known HLA class I with only nine main functional binding specificities. The practical implications of this finding, as well as its relevance to understanding the functional implication of MHC polymorphism in humans, are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individual HLA-I alleles are classified into 12 discrete supertypes (52, 53), on the basis of similar peptide-anchor–binding specificities (26, 52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
In the citing paper
“These supertypes together cover most HLA-A and HLA-B alleles found in distinct populations (52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [52]
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411 · cited 5×
“Independent observations demonstrate that the motif of the mouse class I allele L is identical to the B7-supermotif (Corr et al. 1992; Falk et al. 1991) While the necessary task of fully exploring and cataloging MHC polymorphism continues, we have begun to appreciate the common denominators and similarities hidden wit…”
BackgroundInfluentialRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 4×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundInfluentialGoulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116 · cited 1×
“…also allows focusing of immune responses against multiple conserved epitopes, a factor of crucial importance in the case of rapidly mutating pathogens, such as HIV and HCV (Borrow et al. 1997; Cooper et al. 1999; Goulder et al. 1997a, b; Nowak et al. 1995; Price et al. 1997; Weiner et al. 1995).”
BackgroundRefined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution
Saper, M. A., Bjorkman, P. J., & Wiley, D. C. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90567-p · Cited by 1,077 · cited 2×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains (Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundMethodThe Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020 · cited 1×
“The complex of a major histocompatibilty complex (MHC) molecule and a peptidic antigen acts as the ligand recognized by MHC-restricted T cells (Garcia et al. 1999; Germain and Margulies 1993; Yewdell and Bennink 1999).”
BackgroundCrystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K b
Fremont, D. H., Matsumura, M., Stura, E. A., Peterson, P. A., & Wilson, L. A. (1992) · Science · doi:10.1126/science.1323877 · Cited by 861 · cited 1×
“X-ray crystallographic analysis of MHC-peptide complexes revealed allele specific pockets within the peptide binding cleft of MHC molecules which accommodate specific peptide side chains ( Fremont et al. 1992; Guo et al. 1992; Madden et al. 1992; Matsumura et al. 1992; Saper et al. 1991).”
BackgroundSette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5586 · Cited by 830 · cited 1×
“…peptide-MHC binding have also been established (Engelhard 1994; Joyce and Natheson 1994; Sette and Grey 1992; Sidney et al. 1998), and the threshold of affinity associated with generation of immune responses has also been elucidated (Schaeffer et al. 1989; Sette et al. 1994; Southwood et al. 1998).”
BackgroundSelf-citationIdentification of self peptides bound to purified HLA-B27
Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., & Wiley, D. C. (1991) · Nature · doi:10.1038/353326a0 · Cited by 827 · cited 5×
“Pool sequencing motifs for peptides bound to HLAB*1401-02, B*1503, B*1509, B*1510, B*1518, B*380102, B*3901, B*3902, B*3903-04, B*4801-02, B*7301, and B*2701-08 (Barber et al. 1996a, 1997; Boisgérault et al. 1996; DiBrino et al. 1994b; Falk et al. 1995c; Rötzschke et al. 1994; Garcia et al. 1997; Jardetzky et al. 1991…”
BackgroundInfluential
Cited by
Items 401–500 of 636
Antal, Z., Baker, J. C., Smith, C., Jarchum, I., Babad, J., Mukherjee, G., Yang, Y., Sidney, J., Sette, A., Santamaría, P., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102930 · Cited by 14
“The A3 supertype is characterized by a Bpocket specificity (position 2 of the peptide) for the amino acids A, I, L, M, V, S, or T, and an F-pocket specificity (peptide C terminus) for R or K (39).”
BackgroundResultSelf-citationT-Cell Epitope Discovery for Therapeutic Cancer Vaccines
Krishna, S., & Anderson, K. S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3387-7_45 · Cited by 16
The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding
Shen, W.-J., Zhang, X., Zhang, S., Liu, C., & Cui, W. (2018) · Molecules · doi:10.3390/molecules23113034 · Cited by 14
“The first class I HLA supertypes were proposed by [5], who defined nine supertypes based on clustering the structural motifs derived from experimentally-determined binding data.”
BackgroundMatsueda, S., Yamada, A., Takao, Y., Tamura, M., Komatsu, N., Yutani, S., Ide, T., Sata, M., & Itoh, K. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0284-5 · Cited by 13
“investigated epitopes recognized by both the cellular and humoral immunities of HCV1b-infected patients with HLA-A11, -A31, and -A33, which are major members of A3 supertype [18, 19].”
BackgroundChristensen, J. K., Lamberth, K., Nielsen, M., Lundegaard, C., Worning, P., Lauemøller, S. L., Buus, S., Brunak, S., & Lund, O. (2003) · Neural Computation · doi:10.1162/089976603322518803 · Cited by 13
Gao, Y., Sun, Z., Qi, F., Qi, Y., Zhai, M., Lou, H.-P., Chen, L., Li, Y., & Wang, X. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.009 · Cited by 13
“Thus, about 80% of COX-2 patients could be considered for immunological therapies [22,23].”
BackgroundBuseyne, F., Chaix, M., Rouzioux, C., Blanche, S., & Rivière, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4941-4946.2001 · Cited by 13
“Indeed, HLA-B53 belongs to the B7 supertype, whereas HLA-B57 has been proposed to belong to the distinct HLAB58 supertype (24).”
BackgroundInfluentialSeeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
Yue, C., Wang, P., Tian, J., Gao, G. F., Liu, K., & Liu, W. J. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.80468 · Cited by 13
Neto, T. A. P., Sidney, J., Grifoni, A., & Sette, A. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01083-0 · Cited by 13
Self-citationMishra, S., Lavelle, B. J., Desrosiers, J., Ardito, M. T., Terry, F. E., Martin, W. D., Groot, A. S. D., & Gregory, S. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104606 · Cited by 12
“Toward this end, immunoinformatics tools were used to predict 19 HLA-A*0201-restricted epitopes and 19 promiscuous, HLA-DRB1-restricted immunogenic consensus sequences (ICS, each composed of 5–28 epitopes), which were highlyconserved among HCV genotypes 1a and 1b [14].”
BackgroundGuo, J., Wang, D., Dong, Y., Gao, X., Tong, H., Liu, W., Zhang, L., & Sun, M. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101546 · Cited by 18
Identification of immunodominant T cell epitopes induced by natural Zika virus infection
Eickhoff, C. S., Meza, K. A., Terry, F. E., Colbert, C. G., Blazevic, A., Gutiérrez, A. H., Stone, E. T., Brien, J. D., Pinto, A. K., Sahly, H. M. E., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1247876 · Cited by 12
Chen, F., Zhai, M., Zhu, Y., qi, Y., Zhai, W., & Gao, Y. (2012) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2012.00470.x · Cited by 12
Karlsson, I., Kløverpris, H. N., Jensen, K. J., Stryhn, A., Buus, S., Karlsson, A. C., Vinner, L., Goulder, P., & Fomsgaard, A. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0081 · Cited by 14
“19,20 The selected vaccine epitopes were originally predicted by artificial neural network computers 14,21 and the peptide-HLA binding predicted using the pan-specific NetMHCpan method.”
Botten, J., Sidney, J., Mothé, B. R., Peters, B., Sette, A., & Kotturi, M. F. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-09 · Cited by 14
“However, it should be possible to achieve essentially 100% coverage by identifying CD8 T cell epitopes restricted by additional HLA supertypes, such as A01, A24, B07, and B44, and CD4 T cell epitopes restricted by the HLA-DR supertype (84, 88).”
BackgroundSelf-citationLasso, P., Beltrán, L., Guzmán, F., Rosas, F., Thomas, M. C., López, M. C., González, J. M., Cuéllar, A., & Puerta, C. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150996 · Cited by 14
The Evolution of Alloimmunity and the Genesis of Adaptive Immunity
Gould, S. J., Hildreth, J. E. K., & Booth, A. M. (2004) · The Quarterly Review of Biology · doi:10.1086/426088 · Cited by 15
“In many cases it is difficult to understand the biochemical basis for fitness differences between MHC alleles (Wills 1991; Parham and Ohta 1996; Hughes and Yeager 1998; Sette and Sidney 1998, 1999; Meyer and Thomson 2001).”
Backgroundvan Deutekom, H. W. M., Hoof, I., Bontrop, R. E., & Keşmir, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102236 · Cited by 13
Definition of MHC Supertypes Through Clustering of MHC Peptide Binding Repertoires
Reche, P. A., & Reinherz, E. L. (2004) · Lecture notes in computer science · doi:10.1007/978-3-540-30220-9_15 · Cited by 18
“Interestingly, groups of several HLA molecules (supertypes) can bind largely overlapping sets of peptides [12, 13].”
BackgroundInference on the strength of balancing selection for epistatically interacting loci
Buzbas, E. O., Joyce, P., & Rosenberg, N. A. (2011) · Theoretical Population Biology · doi:10.1016/j.tpb.2011.01.002 · Cited by 11
“The numbers of alleles for the HLA loci are based on supertypes, as defined by Sette and Sidney (1999).”
Identification of HLA Class I-Associated Amino Acid Polymorphisms in the HIV-1C Proteome
Boutwell, C. L., & Essex, M. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0131 · Cited by 11
“30,31 It was not possible to stratify all sequences into supertype classes for two reasons: (1) most supertype assignments are made at the four-digit resolution, thereby excluding the majority of two-digit resolution alleles and (2) many of the four-digit alleles in the datasets have not yet been…”
Sources of diversity in T cell epitope discovery
Chang, C. X. L., Dai, L., Tan, Z. W., Choo, J. A. L., Bertoletti, A., & Grotenbreg, G. M. (2011) · Frontiers in bioscience · doi:10.2741/3895 · Cited by 13
Kusi, K. A., Aggor, F. E. Y., Amoah, L. E., Anum, D., Nartey, Y. A., Amoako-Sakyi, D., Obiri‐Yeboah, D., Hollingdale, M. R., Ganeshan, H. D., Belmonte, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228177 · Cited by 13
“Most of the HLA supertypes that recognize and present the four identified peptides are believed to occur at high frequency in many ethnicities including Africans [27,37], hence HLA restriction of T cell responses to these peptides may ultimately not be the major obstacle to this T cell-based vaccine development approa…”
BackgroundAn immunogenetic view of COVID-19
Aguiar, V. R. C., Augusto, D. G., Castelli, E. C., Hollenbach, J. A., Meyer, D., Nunes, K., & Petzl‐Erler, M. L. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2021-0036 · Cited by 15
Mortier, M.-C., Jongert, E., Mettens, P., & Ruelle, J.-L. (2015) · BMC Immunology · doi:10.1186/s12865-015-0119-7 · Cited by 16
“Collectively these supertypes have been reported to cover 80–90 % of any given human population worldwide, regardless of ethnicity [39].”
Backgroundvan Luijn, M. M., van de Loosdrecht, A. A., Lampen, M. H., van Veelen, P. A., Zevenbergen, A., Kester, M. G. D., de Ru, A. H., Ossenkoppele, G. J., van Hall, T., & van Ham, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034649 · Cited by 11
“The same accounts for HLA-A0301 and -B4002, which represent the common supertypes A3 and B40 [36].”
InfluentialKotraiah, V., Phares, T. W., Terry, F. E., Hindocha, P., Silk, S. E., Nielsen, C. M., Moise, L., Tucker, K. D., Ashfield, R., Martin, W. D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690348 · Cited by 10
“These specific alleles were selected because they are the most common HLA molecules within each of the HLA-DRB1 supertypes (38, 39) and are representative of >95% of human populations worldwide without the need to test each individual haplotype (28, 29).”
BackgroundMethodInfluence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation
Racapé, J., Connan, F., Hoebeke, J., Choppin, J., & Guillet, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609029103 · Cited by 11
Galluzzo, M., D’Adamio, S., Campione, E., Bianchi, L., & Talamonti, M. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0354-8 · Cited by 11
Rare HLA Drive Additional HIV Evolution Compared to More Frequent Alleles
Rousseau, C. M., Lockhart, D. W., Listgarten, J., Maley, S. N., Kadie, C. M., Learn, G. H., Nickle, D. C., Heckerman, D. E., Deng, W., Brander, C., et al. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0208 · Cited by 14
Immunity to liver stage malaria: Considerations for vaccine design
Taylor-Robinson, A. W. (2003) · Immunologic Research · doi:10.1385/ir:27:1:53 · Cited by 12
Lou, Q., Kelleher, R. J., Sette, A., Loyall, J. L., Southwood, S., Bankert, R. B., & Bernstein, S. H. (2004) · Blood · doi:10.1182/blood-2004-01-0105 · Cited by 11
Self-citationChong, L. C., & Khan, A. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00226-8 · Cited by 11
Tsuda, B. (2012) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000159 · Cited by 10
“Because the major HLA types are significantly different across races [10], it is necessary to select a peptide that binds to the HLA of patients of a particular race.”
BackgroundTerasaki, Y., Shichijo, S., Niu, Y., Komatsu, N., Noguchi, M., Todo, S., & Itoh, K. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0699-2 · Cited by 12
“Sidney and colleagues have pointed out that, among 945 diVerent HLA-A and -B alleles examined to date, over 80% can be assigned to one of the nine subtypes, whereas the remaining alleles might be associated with repertoires that overlap multiple supertypes [8, 24, 25].”
BackgroundMa, B. J., & Kane, K. P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002809 · Cited by 9
“The P2 residue of bound peptide is typically held in the Bpocket, and RT1-A1 shares the B-pocket amino acid residues Y7, N63, I66, Y67, and Y99 seen with other molecules of the HLA-B7 supertype (9).”
BackgroundInfluentialJoyce, S., & Ternette, N. (2021) · PROTEOMICS · doi:10.1002/pmic.202000143 · Cited by 10
“[68–70,73–75] discovered that all the currently known HLA-A and HLA-B molecules can be grouped into functional ’supertypes‘ predicatedonpocketsBandFofmembersof each supertypehaving a shared physico-chemical architecture [70].”
BackgroundStructure of HLA-A*1101 in complex with a hepatitis B peptide homologue
Blicher, T. H., Kastrup, J. S., Pedersen, L. Ø., Buus, S., & Gajhede, M. (2006) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309106044228 · Cited by 10
“Studies of the many MHC-I alleles have allowed a grouping based on peptide-binding preferences and so far 12 different supertypes have been identified (Lund et al., 2004; Sette & Sidney, 1999).”
BackgroundSaethang, T., Hirose, O., Kimkong, I., Vu, T. A., Dang, X. T., Nguyen, L. A., Le, T. K. T., Kubo, M., Yamada, Y. M. A., & Satou, K. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-313 · Cited by 10
“This suggested that A*24:02 itself is different from other alleles considered here, and this might be the reason why most of the previous studies assigned it separately to the A24 group [34-37].”
MethodResultEvidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission
Ngandu, N. K., Seoighe, C., & Scheffler, K. (2009) · Virology Journal · doi:10.1186/1743-422x-6-164 · Cited by 10
“This allele has anchor residue motif restrictions that are shared within the HLA A3 supertype, the second most frequent supertype in the human population [49].”
BackgroundStructural Basis for HLA-A2 Supertypes
Kangueane, P., & Sakharkar, M. K. (2007) · Methods in molecular biology · doi:10.1007/978-1-60327-118-9_10 · Cited by 10
Epstein-Barr virus vaccine: a cytotoxic T-cell-based approach
Bharadwaj, M., & Moss, D. J. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.4.467 · Cited by 10
MHC-bound antigens and proteomics for novel target discovery
Shoshan, S. H., & Admon, A. (2004) · Pharmacogenomics · doi:10.1517/14622416.5.7.845 · Cited by 12
“One key issue in epitope-based vaccine development is taking into account the nine major HLA class I supertypes [86].”
BackgroundDuvvuri, V. R. S. K., Marchand‐Austin, A., Eshaghi, A., Patel, S. N., Low, D. E., & Gubbay, J. B. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.054 · Cited by 10
Pandey, R. K., Ojha, R., Chatterjee, N., Upadhyay, N., Mishra, A., & Prajapati, V. K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27531 · Cited by 9
“…and B7 were selected because these supertypes covers around 88.9% of the world’s population (Pandey, Ojha, Aathmanathan, Krishnan, & Prajapati, 2018; Sette & Sidney, 1999) and used to predict the CTL epitopes for each protein and the one with highest combined score was selected from each supertype…”
MethodInfluentialVinner, L., Holmgren, B., Jensen, K. J., Esbjörnsson, J., Borggren, M., Hentze, J. L., Karlsson, I., Andresen, B. S., Gram, G. J., Kløverpris, H. N., et al. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02763.x · Cited by 10
Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A26 allele
Sakamoto, S., Matsueda, S., Takamori, S., Toh, U., Noguchi, M., Yutani, S., Yamada, A., Shichijo, S., Yamada, T., Suekane, S., et al. (2015) · Cancer Science · doi:10.1111/cas.12757 · Cited by 9
Jansen, D. T. S. L., de Beijer, M. T. A., Luijten, R. J., Kwappenberg, K. M. C., Wiekmeijer, A., Kessler, A. L., Pieterman, R. F. A., Bouzid, R., Krebber, W.-J., de Man, R. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1163118 · Cited by 10
“HLA types, however, were heterogenous in the resolver cohort and covered each of the six aforementioned prevalent HLA supertypes (A1, A2, A3, A24, B7, and B8) including also some of the HLA subtypes most prevalent in Asia (i.e., A11 and A24), where cHBV prevalence is high (39).”
Abdel-Hady, K. M. A., Gutiérrez, A. H., Terry, F. E., Desrosiers, J., Groot, A. S. D., & Azzazy, H. M. E.-S. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29177 · Cited by 9
“Identification and validation of HLA class I epitopes By using the epitope prediction and conservation analysis tools of the iVAX toolkit (EpiMatrix and Conservatrix, respectively), the amino acid sequences of the precursor polyprotein genes of 46 HCV-4 genomic sequences were parsed into 32 286 nine-amino-acid-long pe…”
MethodResultInfluentialHLA-B51 gene and its expression in association with Behçet’s Disease in Denizli Province of Turkey
Atalay, A., Yıldız, S., Tatlıpınar, S., Şanlı-Erdoğan, B., Çobankara, V., Yıldırım, C., Bağcı, H., & Atalay, E. Ö. (2007) · Molecular Biology Reports · doi:10.1007/s11033-007-9092-4 · Cited by 9
“(NKB1) and associated with selective inhibition of NK cell cytotoxicity [12–15, 20, 34].”
Deciphering complex patterns of class‐I HLA–peptide cross‐reactivity via hierarchical grouping
Mukherjee, S., Warwicker, J., & Chandra, N. R. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.3 · Cited by 10
Scharnagl, N. C., & Klade, C. S. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.4.605 · Cited by 9
A Novel Tuberculosis Antigen Identified from Human Tuberculosis Granulomas*
Yang, Y., Jin, D., Hu, S., Zhang, Y., Zheng, X., Zheng, J., Liao, M., Chen, X., Graner, M. W., Liu, H., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.045237 · Cited by 9
Lavender, K. J., & Kane, K. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8578 · Cited by 9
“and HLA-B7 supertype anchor residue (19).”
BackgroundInfluentialKamoun, M., Israni, A. K., Joffe, M. M., Hoy, T., Kearns, J., Mange, K. C., Feldman, D., Goodman, N., Rosas, S. E., Abrams, J. D., et al. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.009 · Cited by 9
Wang, G., Wan, H., Jian, X., Li, Y., Ouyang, J., Tan, X., Zhao, Y., Lin, Y., & Xie, L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/697011 · Cited by 12
Chick, J. A., Abongdia, N. N., Shey, R. A., & Apinjoh, T. O. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42014 · Cited by 8
Ouattara, A., Dwivedi, A., Adams, M., Niangaly, A., Laurens, M. B., Nyunt, M. M., Plowe, C. V., DJIMDÉ, A. A., Takala‐Harrison, S., & da Silva, J. C. F. (2022) · Microorganisms · doi:10.3390/microorganisms10061090 · Cited by 8
“These HLA types are part of the three supertypes (HLA-A2, -A3, and -B7) [45,46].”
BackgroundEfficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine
Cen, L., Zhang, Z., Sun, Y., Wu, N., Shao, J., Qian, Z., Tian, M., Ke, Y., & Liu, B. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03421-2 · Cited by 9
“Simultaneously, the choice of alleles was predicated upon the principles and attributes of the HLA supertype [31, 32].”
BackgroundKessler, A. L., Fort, K. L., Resemann, H. C., Krüger, P., Wang, C., Koch, H., Hauschild, J.-P., Marino, F., & Heck, A. J. R. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101049 · Cited by 13
“…selected because of their potential clinical relevance, as they collectively cover most of the world population in terms of HLA allele expression (63–65) but also to further understand how EThcD can help uncover the “HCD-undetectable” immunopeptidome across a wide range of HLA alleles (Table 1).”
Immune Parameters to Consider When Choosing T-Cell Receptors for Therapy
Burrows, S. R., & Miles, J. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00229 · Cited by 8
“Based on HLA structural similarities and overlapping peptide binding motifs, nine major HLA supertypes have been proposed (62).”
BackgroundLundegaard, C., Buggert, M., Karlsson, A. C., Lund, O., Pérez, C. L., & Nielsen, M. (2010) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/1854776.1854905 · Cited by 8
“This pool was identified using the NetCTL method for CTL epitope prediction [3], for seven prevalent HLA supertypes [4, 5] (A1, A2, A3, A24, B7, B44, and B58), and the EpiSelect algorithm, which can identify epitopes with both broad coverage of the pathogen genomic variation and cross reactivity to many different path…”
MethodBiological implication for loss of function at major histocompatibility complex loci
Sawai, H., Go, Y., & Satta, Y. (2008) · Immunogenetics · doi:10.1007/s00251-008-0291-5 · Cited by 8
“A binding peptide repertoire of a single molecule in a supertype is overlapped to that of the other members in the supertype and some share almost identical peptide-binding specificity (Southwood et al. 1998; Sette and Sidney 1999).”
BackgroundKumar, A. A., Kumar, S., Le, T. P., Southwood, S., Sidney, J., Cohen, J., Sette, A., & Hoffman, S. L. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2766-2771.2001 · Cited by 8
“Recent data also suggest that HLA-A*01 might represent a prototype allele of an HLA-A1 supertype composed of several alleles with similar peptide-binding motifs (22).”
BackgroundSelf-citationKumar, V., Prakash, O., Manpreet, S., Sumedh, G., & Medhi, B. (2006) · PubMed · Cited by 9
Lavender, K. J., Ma, B. J., Silver, E. T., & Kane, K. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3518 · Cited by 8
“In humans, although class I alleles exhibit extensive diversity, they can be grouped into only nine supertypes (58) when the variation of anchor residues is considered.”
BackgroundThe ultimate mix and match: making sense of HLA alleles and peptide repertoires
Cole, D. K. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.40 · Cited by 8
McNicholl, J. M., & Promadej, N. (2004) · Immunologic Research · doi:10.1385/ir:29:1-3:161 · Cited by 11
Nuclear Export Signal and Immunodominant CD8+T Cell Epitope in Influenza A Virus Matrix Protein 1
Terajima, M., & Ennis, F. A. (2012) · Journal of Virology · doi:10.1128/jvi.00894-12 · Cited by 8
“Considering that the HLA-A*0201 allele or alleles belonging to the HLA-A2 supertype are very common in the human population (more than 40%) (12), it is expected that escape mutation may emerge in the M1 CD8 T cell epitope.”
BackgroundRole of MHC class I pathways in Mycobacterium tuberculosis antigen presentation
Witt, K. D. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1107884 · Cited by 12
“In humans, the most commonly found alleles are clustered into three major groups A–C, and 42 core classical types further grouped into 12 supertypes based on the similarities in peptide-binding motifs (Sette and Sidney, 1999).”
BackgroundUsing bioinformatics to investigate functional diversity: a case study of MHC diversity in koalas
Silver, L. W., McLennan, E. A., Beaman, J. E., da Silva, K. B., Timms, P., Hogg, C. J., & Belov, K. (2024) · Immunogenetics · doi:10.1007/s00251-024-01356-6 · Cited by 7
“Supertypes are alleles that share similar biochemical properties (Sette and Sidney 1999; Sidney et al. 1996).”
BackgroundA molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination
Suryadevara, N., Kumar, A., Ye, X., Rogers, M. C., Williams, J. V., Wilson, J. T., Karijolich, J. J., & Joyce, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-21620-7 · Cited by 8
Low level of HIV-1 evolution after transmission from mother to child
Gijsbers, E. F., van Nuenen, A. C., de la Peña, A. T., Bowles, E. J., Stewart-Jones, G. B. E., Schuitemaker, H., & Kootstra, N. A. (2014) · Scientific Reports · doi:10.1038/srep05079 · Cited by 8
Obara, I., Nielsen, M., Jeschek, M., Nijhof, A. M., Mazzoni, C. J., Svitek, N., Steinaa, L., Awino, E., Olds, C., Jabbar, A., et al. (2016) · Immunogenetics · doi:10.1007/s00251-016-0902-5 · Cited by 7
Identification of novel HLA-A11-restricted T-cell epitopes in the Ebola virus nucleoprotein
Li, D. X., Li, P., Song, N., Jiang, Y., Zeng, Y., Zhao, G., Fa, Y., Ye, H., Lone, Y. C., Zhou, Y., et al. (2018) · Microbes and Infection · doi:10.1016/j.micinf.2018.04.005 · Cited by 7
Origins and relatedness of human leukocyte antigen class I allele supertypes
Naugler, C. T. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.06.010 · Cited by 7
Schalich, J., Vytvytska, O., Zauner, W., Fischer, M. B., Buschle, M., Aichinger, G., & Klade, C. S. (2008) · Biological Chemistry · doi:10.1515/bc.2008.065 · Cited by 7
“Similarly, DDVWTSGSDSDE397–408, described as HLA-B35 restricted (0/9 subjects), reacted in one of the B7-positive donors, in line with the concept of HLA superfamilies (Sette and Sidney, 1999).”
ResultStatic Energy Analysis of MHC Class I and Class II Peptide-Binding Affinity
Davies, M. N., & Flower, D. R. (2007) · Methods in molecular biology · doi:10.1007/978-1-60327-118-9_23 · Cited by 7
Gomez‐Perosanz, M., Russo, G. L., Lopez, J. L. S.-T., Pennisi, M. A., Reche, P. A., Shepherd, A. J., & Pappalardo, F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20452-4 · Cited by 9
ImmunoStruct enables multimodal deep learning for immunogenicity prediction
Givechian, K. B., Rocha, J. F., Liu, C., Yang, E., Tyagi, S., Greene, K., Ying, R., Caron, É., Iwasaki, A., & Krishnaswamy, S. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-01163-y · Cited by 17
“The cancer peptide–MHC sequence data were obtained as previously described and filtered to the same allele set 19,46,52,61 .”
Youk, S., Kang, M., Ahn, B., Koo, Y., & Park, C. (2023) · Genes · doi:10.3390/genes15010007 · Cited by 6
“Specifically, the PBR of MHC class I molecules contains six distinct binding pockets labeled A through F, which anchor antigenic peptides [7–10].”
BackgroundMethodChen, J., Tan, S., Avadhanula, V., Moise, L., Piedra, P. A., Groot, A. S. D., & Bahl, J. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010360 · Cited by 6
“These are HLA allele supertypes (alleles sharing common binding preferences) that cover the genetic diversity of more than 95% of human populations globally [51,52].”
BackgroundCharacterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06
Sidney, J., Schloss, J. M., Moore, C., Lindvall, M., Wriston, A., Hunt, D. F., Shabanowitz, J., DiLorenzo, T. P., & Sette, A. (2016) · Immunogenetics · doi:10.1007/s00251-015-0898-2 · Cited by 6
“Confirming previous predictions, both alleles were found to recognize a motif that largely overlaps with the HLA B27 supermotif (Sette and Sidney 1999).”
Self-citationSakamoto, S., Matsueda, S., Takamori, S., Toh, U., Noguchi, M., Yutani, S., Yamada, A., Shichijo, S., Yamada, T., Suekane, S., et al. (2017) · Cancer Science · doi:10.1111/cas.13189 · Cited by 6
Peptide immunization excludes antigen‐specific T cells from splenic lymphoid compartments
Zhang, L., Lizzio, E. F., Chen, T., & Kozlowski, S. (2005) · European Journal of Immunology · doi:10.1002/eji.200425479 · Cited by 6
A CD8 T-Cell Epitope Variant Enhances Immune Targeting to a Recombinant Picornavirus Vaccine Antigen
Bell, M. P., Renner, D. N., Johnson, A. J., & Pavelko, K. D. (2014) · Viral Immunology · doi:10.1089/vim.2014.0045 · Cited by 6
Levitsky, V., Liu, D., Southwood, S., Levitskaya, J., Sette, A., & Masucci, M. G. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00179-8 · Cited by 6
Self-citationBilderbeek, R. J. C., Baranov, M. V., van den Bogaart, G., & Bianchi, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763044 · Cited by 5
“6% coverage of the population’s MHC-I repertoire as defined by (1, 21), and the 21”
BackgroundOptimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
Baleeiro, R. B., Chard, L. S., Liu, P., Lu, S., Lone, Y. C., Lemoine, N. R., & Wang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.902709 · Cited by 6
“The HLA-A*03:01 and HLA-A*11:01 alleles belong to the same family and share similar binding capacity to many peptides (29).”
BackgroundKopat, V. V., Riabchenkova, A. A., Chirak, E. L., Chirak, E. R., Saenko, A. I., Колмаков, Н. Н., Simbirtsev, A. S., Dukhovlinov, I. V., & Тотолян, А. А. (2023) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-dsa-15624 · Cited by 5
A biochemical and structural analysis of genetic diversity within the HLA-A*11 subtype
Li, L., Chen, W., & Bouvier, M. (2005) · Immunogenetics · doi:10.1007/s00251-005-0801-7 · Cited by 5
“Owing to these differences within their corresponding F pockets, -Aw*6801 belongs to the HLA-A3 superfamily and -Aw*6802 belongs to the HLA-A2 superfamily (Sette and Sidney 1999).”
BackgroundDesigning HIV gp120 Peptide Vaccines: Rhetoric or Reality for Neuro-AIDS
Kangueane, P., Kayathri, R., Sakharkar, M. K., Flower, D. R., Sadler, K. E., Chiappelli, F., Segal, D. M., & Shapshak, P. (2014) · ASM Press eBooks · doi:10.1128/9781555815691.ch9 · Cited by 5
A Statistical Framework for Modeling HLA-Dependent T Cell Response Data
Listgarten, J., Frahm, N., Kadie, C. M., Brander, C., & Heckerman, D. E. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030188 · Cited by 6
“Prior to this study (partially reported in [26]), it was thought that HLA class I epitopes were restricted mainly by a single HLA allele, or if by more than one allele, then only a few that were structurally highly related and commonly fell into the same HLA supertype [27] (supertypes group together HLA alleles with s…”
ResultZhang, S., Chen, J., Hong, P., Li, J., Tian, Y., Wu, Y., & Wang, S. (2019) · Journal of Immunological Methods · doi:10.1016/j.jim.2019.112685 · Cited by 8
da Costa, A. S., Fernandes, T. V. A., Bello, M. L., & de Souza, T. L. F. (2021) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2021.107459 · Cited by 6
Sun, B., Zhang, J., Wang, J., Liu, Y., Sun, H., Lü, Z., Chen, L., Ding, X., Pan, J., Hu, C., et al. (2022) · Vaccines · doi:10.3390/vaccines10040564 · Cited by 5
“3% of the population [9] were predicted by combining five authentic methods.”
MethodZhao, J., Yan, M., Shi, G., Zhang, S.-L., & Ming, L. (2017) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7207 · Cited by 6
“In this study, HLA-A2, A3, and B7 supertypes were included in this analysis, as they were the most common HLA Class I supertypes across ethnicities, with an estimated frequency of > 80% [8].”
BackgroundMethodMehra, N. K., Kaur, G., & Jaini, R. (2002) · Public Health Genomics · doi:10.1159/000066330 · Cited by 5
“Recent molecular technologies have defined the high level of genetic diversity in the human major histocompatibility complex (MHC). The extreme degree of polymorphism in the MHC poses limitations for the development of potentially global vaccines for infectious diseases. The HLA system that is the MHC of man already h…”
Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites
Ishiyama, S., Matsueda, S., Jones, L. A., Efferson, C. L., Celestino, J., Schmandt, R. E., Ioannides, C. G., Tsuda, N., & Chang, D. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.889 · Cited by 5
Identification and functional perspective of a novel HLA-A allele: A*0279
Liu, F., Wang, S., Ye, Y., Zhang, H., Zhang, Y., & Chen, W. (2006) · Immunogenetics · doi:10.1007/s00251-006-0087-4 · Cited by 5
“The ever-increasing number of HLA alleles has led to the development of the concept of HLA supertypes, by which the large number of HLA allelic variants are grouped into a few families on the basis of their peptide-binding specificities (Sette and Sidney 1998, 1999; Sidney et al. 1996).”
Background
Metadata
- Authors
- Sette, A., & Sidney, J.
- ORCID
- Venue
- Immunogenetics
- Published
- 1999-11
- Volume
- 50
- Issue
- 3-4
- Pages
- 201-212
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2052321000
- Cited by
- 635
- References
- 115
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 18 · 2022: 16 · 2021: 21 · 2020: 25 · 2019: 14 · 2018: 20 · 2017: 19 · 2016: 14 · 2015: 26 · 2014: 26 · 2013: 27 · 2012: 37
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Immunogenetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ai045241-010, n01ai095362-000)
- National Institute of Allergy and Infectious Diseases (N01 AI-45241, N01-AI-95362)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- HLA-A, HLA-B, MHC polymorphism
- MeSH terms
- Alleles, Amino Acid Sequence, Animals, Epitopes, Humans, Molecular Sequence Data, Polymorphism, Genetic, HLA-A Antigens, HLA-B Antigens, Histocompatibility Antigens Class I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.